Literature DB >> 13680830

The role of Urtica dioica and Nigella sativa in the prevention of carbon tetrachloride-induced hepatotoxicity in rats.

M K Türkdoğan1, H Ozbek, Z Yener, I Tuncer, I Uygan, E Ceylan.   

Abstract

The role of Nigella sativa L. (Ranunculaceae) (NS) and Urtica dioica L. was investigated (UD) in the prevention of carbon tetrachloride (CCl4) induced liver fibrosis and cirrhosis. Fifty Sprague-Dawley rats were allocated into fi ve groups (I, IIA and B, IIIA and B) and CCl4 was injected biweekly to all groups. Group I (control, CCl4 only), group IIA and B (NS fixed oil and volatile oil), group IIIA and B (UD fixed oil and UD decoction extract) rats were killed at the end of week 12 and histopathological and immunohistochemical examinations of liver tissues were performed. In the control group, coagulation necrosis and hydropic degeneration were marked in the periacinar regions (zone 3) associated with fibrosis in the periacinar regions and in the portal tracts. In groups IIA-B and IIIA-B (NS and UD), none of the serious histopathological findings were detected except for sparse coagulation necrosis in the periacinar regions. ASMA-positive perisinusoidal cells with myo fibroblastic transformation and lysosomal enzyme activity suggesting fibrogenesis were also significantly more common in the control group than in the NS and UD groups. UD and NS seem to be significantly effective in the prevention of carbon tetrachloride induced hepatotoxicity in rats. Copyright 2003 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 13680830     DOI: 10.1002/ptr.1266

Source DB:  PubMed          Journal:  Phytother Res        ISSN: 0951-418X            Impact factor:   5.878


  8 in total

1.  Hepatoprotective effects of Nigella sativa L and Urtica dioica L on lipid peroxidation, antioxidant enzyme systems and liver enzymes in carbon tetrachloride-treated rats.

Authors:  Mehmet Kanter; Omer Coskun; Mustafa Budancamanak
Journal:  World J Gastroenterol       Date:  2005-11-14       Impact factor: 5.742

2.  Antimalarial and antioxidant activities of methanolic extract of Nigella sativa seeds (black cumin) in mice infected with Plasmodium yoelli nigeriensis.

Authors:  Valeelat O Okeola; Oluwatosin A Adaramoye; Chiaka M Nneji; Catherine O Falade; E Olatunde Farombi; Olusegun G Ademowo
Journal:  Parasitol Res       Date:  2010-12-14       Impact factor: 2.289

Review 3.  Anti-diabetic potential of Urtica Dioica: current knowledge and future direction.

Authors:  Anita Chehri; Reza Yarani; Zahra Yousefi; Tannaz Novin Bahador; Seyed Kazem Shakouri; Alireza Ostadrahimi; Majid Mobasseri; Flemming Pociot; Mostafa Araj-Khodaei
Journal:  J Diabetes Metab Disord       Date:  2022-01-13

4.  Nigella sativa relieves the deleterious effects of ischemia reperfusion injury on liver.

Authors:  Fahrettin Yildiz; Sacit Coban; Alpaslan Terzi; Mustafa Ates; Nurten Aksoy; Hale Cakir; Ali Riza Ocak; Muharrem Bitiren
Journal:  World J Gastroenterol       Date:  2008-09-07       Impact factor: 5.742

5.  Effects of Urtica dioica on hepatic ischemia-reperfusion injury in rats.

Authors:  Hayati Kandis; Sami Karapolat; Umran Yildirim; Ayhan Saritas; Suat Gezer; Ramazan Memisogullari
Journal:  Clinics (Sao Paulo)       Date:  2010       Impact factor: 2.365

6.  Effects of Urtica dioica supplementation on blood lipids, hepatic enzymes and nitric oxide levels in type 2 diabetic patients: A double blind, randomized clinical trial.

Authors:  Alidad Amiri Behzadi; Hamid Kalalian-Moghaddam; Amir Hossein Ahmadi
Journal:  Avicenna J Phytomed       Date:  2016 Nov-Dec

7.  Efficacy of thymoquinone in the treatment of experimental lipopolysaccharide-induced acute lung injury.

Authors:  Mustafa Çolak; Serdar Kalemci; Aylin Özgen Alpaydın; Volkan Karaçam; Ibrahim Meteoğlu; Osman Yılmaz; Bahriye Oya Itil
Journal:  Kardiochir Torakochirurgia Pol       Date:  2020-07-20

Review 8.  Herbal remedies for liver fibrosis: A review on the mode of action of fifty herbs.

Authors:  Uzma Latief; Riaz Ahmad
Journal:  J Tradit Complement Med       Date:  2017-11-22
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.